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Abstract
 
Vitamin A and its biologically active derivatives, the retinoids, are recognized as key regulators
of vertebrate development, cell growth, and differentiation. Although nuclear receptors have
held the attention since their discovery a decade ago, we report here on serine/threonine ki-
nases as a new class of retinoid receptors. The conserved cysteine-rich domain of the NH
 
2
 
-ter-
minal regulatory domains of cRaf-1, as well as several select domains of the mammalian protein
kinase C (PKC) isoforms 
 
a
 
, 
 
d
 
, 
 
z
 
, and 
 
m
 
, the 
 
Drosophila
 
 and yeast PKCs, were found to bind re-
tinol with nanomolar affinity. The biological significance was revealed in the alternate redox
activation pathway of these kinases. Retinol served as a cofactor to augment the activation of
both cRaf and PKC
 
a
 
 by reactive oxygen, whereas the classical receptor-mediated pathway was
unaffected by the presence or absence of retinol. We propose that bound retinol, owing to its
electron transfer capacity, functions as a tag to enable the efficient and directed redox activation
of the cRaf and PKC families of kinases.
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Introduction
 
In the World Health Organization’s estimate, vitamin A
deficiency causes blindness in 1.5 million children and clin-
ical xerophthalmia in a 10-fold larger cohort. Both groups
suffer from immune dysfunction, commonly associated
with vitamin A deficiency, which puts these children at
high risk for their health and normal development (1). The
adverse consequences of vitamin A deficiency on immune
system development were first described over 70 years ago
(2). The underlying mechanism was studied extensively in
the following decades (3) but has remained hidden. As ret-
inoic acid was not capable of completely reversing the im-
mune deficiency, the involvement of other vitamin A me-
tabolites has been postulated. In the 1990s, while studying
an intro model of vitamin A deficiency (4), we discovered
14-hydroxy-
 
retro
 
-retinol (14HRR) and 13,14-dihydroxy-
retinol (DHR) as the likely mediators of normal immune
function, since both compounds, but not retinoic acid,
substituted for vitamin A as regulators of growth and sur-
vival of lymphocytes (5, 6). A strong lead on the mecha-
nism of action emerged with the realization that lack of vi-
tamin A led to programmed cell death in numerous tissues.
Likewise, the action of anhydroretinol proved antagonistic
to the survival-promoting potential of 14HRR and retinol,
by causing apoptosis (7). Because apoptosis occurred un-
usually promptly and without apparent nuclear involve-
ment, and because known retinoic acid receptors (8, 9)
neither bound nor responded to 14HHR, a new class of
receptors of cytoplasmic vitamin A and 14HRR was postu-
lated (10). Results from experiments with kinase blocking
drugs further narrowed the choices and pointed to signal-
ing molecules as direct targets of retinoid action (10).
When finally identified, the surprise was that the receptors
comprised numerous members of well-known signaling
molecules, notably the serine/threonine kinases, protein
kinase C (PKC)
 
1
 
 and cRaf, as detailed in this report.
The family of serine/threonine kinases functions as a sec-
ond tier of signal integration and amplification, connecting
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Abbreviations used in this paper:
 
 AR, anhydroretinol; CRBP, cellular ret-
inol binding protein; ERK, extracellular signal–regulated kinase; FBS, fe-
tal bovine serum; FRET, resonance energy transfer of intrinsic protein
fluorescence; Gst, glutathione 
 
S
 
-transferase; Hsp, heat shock protein;
MAPK, mitogen-activated protein kinase; PKC, protein kinase C; ROS,
reactive oxygen species; trp, tryptophan; ZiF, zinc finger. 
836
 
Zinc Finger Domains Bind Retinoids
 
receptor kinases to various effector pathways, including
transcription, cell cycle control, cell survival, cell move-
ment, and structural remodeling. The serine/threonine ki-
nases exist in inactive form as globular proteins in the cyto-
plasm in complex with several regulatory proteins. The
cRaf signaling module comprises heat shock proteins, im-
munophilins (11), and 14-3-3 (12). The activation mecha-
nism of cRaf is not fully understood, but includes conven-
tional phosphorylation by upstream kinases, translocation
from cytosol to membranes, and mandatory interaction
with GTP/ras (13). PKC follows a different paradigm that
involves binding of a combination of different lipid second
messengers and, depending on isoform, also Ca
 
2
 
1
 
 (14). In
addition to phosphorylation of select amino acids, the con-
version, like cRaf, of cytoplasmic to membrane protein
takes place.
Oxidative activation has been identified as an alternative
pathway. Both cRaf and several PKC isoforms have been
found to respond rapidly to reactive oxygen species (ROS)
in vivo and in vitro (15, 16). This milestone discovery is
apt to lead to an understanding of how changes in the re-
dox microenvironment are sensed by the signaling appara-
tus and converted to biochemical action. The chain of mo-
lecular events leading to enzyme activation is unclear.
Konishi et al. reported that tyrosine phosphorylation in the
catalytic domain of PKC was a prerequisite for activation
by H
 
2
 
O
 
2
 
 (16). The question of whether oxidative activa-
tion is by direct action and, if so, which structures in the
regulatory and/or catalytic domains of PKC and Raf are
modified by redox reaction remains unanswered. The pres-
ence of conserved cysteine-rich, zinc-stabilized structures
in the regulatory domains of cRaf and PKC (17–19) invites
the hypothesis that the initial attack is on the sulfhydryl
groups. By coincidence, our laboratory has found that the
zinc finger (ZiF) domains serve as high affinity binding sites
for retinoids, as reported below. Furthermore, we demon-
strate that retinol serves as cofactor to facilitate the redox
activation of both Raf and PKC kinases. Because retinol
binds to the cysteine-rich domain, the focus of attention is
on this structural element. The ZiF domains of PKC and
Raf not only function as critical regulatory structures in the
classical hormone receptor–mediated pathways, but they
also appear of similar importance in the redox activation
pathway. Although the actual chemical and structural mod-
ifications of the mammalian ZiF domains remain to be
solved, a fitting precedent exists in the prokaryotic chaper-
one, heat shock protein (Hsp)33, where a related ZiF do-
main has been demonstrated to function as a redox switch
(20)—in the absence of retinoids. Oxidizing conditions
have been demonstrated to cause cysteine residues of the
bacterial ZiF domain to form disulfide bonds and conse-
quently to activate the chaperone function. This process
was reversible by reduction with glutathione.
Our work extends the range of actions of retinoids from
the well-known effects in gene transcription (8, 9) and vi-
sion (21), mediated by retinoic acids and retinaldehyde, re-
spectively, to regulation of signal transduction. As stated
above, the broadening of the field has long been predicted
 
since the immune deficiency and male sterility resulting
from experimental vitamin A deficiency in laboratory ani-
mals are never completely reversed by retinoic acid alone.
A third branch of vitamin A action is exemplified by the
redox regulation of serine/threonine kinases by retinol and
its hydroxylated metabolites, 14HRR and DHR (5, 6).
Since the capacity to take up vitamin A and convert it to
14HRR goes beyond immune cells, and includes essen-
tially all nucleated cells, and since all cells utilize PKC and
cRaf in central signal pathways, this new paradigm is likely
to play a fundamental role in signal transduction.
 
Materials and Methods
 
Immunological Reagents
 
Rabbit antibody to the cRaf C20-terminal peptide was pur-
chased from Santa Cruz Biotechnology, Inc. Antibodies to phos-
phorylated and nonphosphorylated extracellular signal–regulated
kinase (ERK)1 and 2 were from New England Biolabs, Inc. Anti-
Flag mAb M2 was from Eastman Kodak Co., and agarose-conju-
gated M2 was from Sigma-Aldrich. mAb to PKC
 
a
 
 was from
Transduction Laboratories.
 
Retinoids
 
All-trans isomers of anhydroretinol (AR), 14HRR, and DHR
were synthesized as described previously (6, 7, 22). Trans-retinol
was purchased from Sigma-Aldrich and purified by high pressure
liquid chromatography on a C18 column. 
 
3
 
H-retinol was pur-
chased from DuPont/NEN Life Science Products.
 
Glutathione S-Transferase Fusion Proteins: Vector Construction, 
Protein Expression, and Purification
 
The following cDNA fragments were used, encoding cysteine-
rich domains of human cRaf-1 with different lengths, corre-
sponding to amino acids 136–186 (devoid of tryptophan [trp]),
136–195 with trp at position 187), and 4–256; the 
 
Drosophila
 
PKC C1A domain (amino acids 40–101) and 
 
Drosophila
 
 C1B
(amino acids 105–261 plus a trp residue at position 262); kinase
suppressor of ras (KSR; amino acids 333–378); and Vav (amino
acids 464–518, with an added trp residue at position 519). The
cDNA fragments were generated by PCR (23, 24). They were
cloned into the BamH1-Sma1 or the BamH1-EcoR1 sites of
pGEX2T (Amersham Pharmacia Biotech). The glutathione 
 
S
 
-trans-
ferase (Gst) fusion proteins were expressed in the BL21/DE3
strain of 
 
Escherichia coli 
 
(Novagen). The growth conditions were
as follows: the bacteria were initially grown at 37
 
8
 
C to an optical
density at 600 nm of 0.5, then transferred to room temperature.
When the optical density reached 0.7–0.8, protein synthesis was
induced by isopropyl-thio-
 
b
 
-
 
d
 
-galactopyranoside, and the cells
were harvested 2 h later. Bacteria were lysed by passing twice
through a French press, and the proteins were purified by affinity
chromatography on the glutathione-agarose matrix (Sigma-Aldrich)
according to a standard protocol. Purity by Coomassie blue stain-
ing of SDS polyacrylamide gels was 
 
.
 
90%.
 
Construction of Flag-cRaf ZiF.
 
The cRaf cys domain was
cloned by PCR using the primers 5
 
9
 
-GAT TTC CTG GAT
AAT TCC CTC ACA ACA CAC and 3
 
9
 
-ACC AAT AGT
GGA ATT GGA TCC CAA TAA CAG TTG TCT. The prod-
uct was inserted into the EcoR1-BamH1 sites of the Sigma-Aldrich
vector pFlag-CMV-2. Fidelity was confirmed by sequencing. 
837
 
Hoyos et al.
 
Binding Assays.
 
Gst fusion proteins were dissolved in PBS.
The latter was purged of oxygen by sparging with helium for 15
min. Fluorescence excitation and emission spectra of protein–ret-
inoid complexes, as well as quantitative fluorescence measure-
ments with retinoid titrations, were carried out in a JASCO
Spectrofluorimeter (model FP777). Protein concentrations were
at 250 nM, and retinoids were added to proteins from 25-
 
m
 
M
stock solutions in methanol. All measurements were repeated two
to four times. Binding constants were calculated by nonlinear
curve fitting according to the theorem by Norris et al. (25).
 
In Vivo Binding Assay.
 
COS-7 cells were transfected by the
calcium phosphate method with DNA encoding Flag-tagged full
length cRaf or the Raf-ZiF domain fragment. Transfected and
control cultures were starved of retinoids for 2 d, then incubated
with 5 nM 
 
3
 
H-retinol for 30 min. To assess binding specificity,
labeled cells were preincubated with indicated concentrations of
cold all-trans retinol. Because at 1 
 
m
 
M and above retinol forms
micelles, these concentrations cannot be evaluated in binding
competition assays. Extracts were prepared by repeated freeze–
thawing, and cRAf proteins were isolated by immunoprecipita-
tion. Immunoprecipitates were washed extensively with saline
containing 0.5 M NaCl and 0.5% bovine albumin, and bound ra-
dioactivity was measured. Results were expressed as differentials
of immunoprecipitates between transfected and nontransfected
cultures.
 
Cell Culture Experiments
 
Retinol Starvation and Reconstitution.
 
NIH 3T3 cells were grown
in 60-mm dishes in MEM high glucose medium supplemented with
7% fetal bovine serum (FBS). Upon reaching half confluence, the
medium was replaced by MEM supplemented with 2 
 
m
 
M BSA,
2 
 
m
 
M linoleic acid, and 70 nM transferrin and culturing was contin-
ued for 4–5 d. To replenish retinoids, sets of cultures received 2 
 
m
 
M
all-trans retinol 12 h before assaying, as specified in the experiments.
 
Stimulation of 3T3 Cells by Reactive Oxygen.
 
To distinguish
cRaf effects from concomitant PKC effects, cultures of 3T3 cells,
depleted of retinol or repleted with retinol, were blocked by cul-
turing in 25 nM staurosporine for 40 min before activation by
ROS. Next, H
 
2
 
O
 
2
 
 was added at concentrations between 300 and
10 
 
m
 
M, and culturing was continued for specified periods of
time. For harvesting, cells were washed with ice-cold PBS and
snap-frozen in 75 
 
m
 
l extraction buffer (buffer A: 50 mM Tris-
HCl, 100 mM NaCl, 1 mM Na
 
3
 
VO
 
4
 
, 100 g/ml PMSF, 10 
 
m
 
g/
ml aprotinin, 10 
 
m
 
g/ml leupeptin). To obtain whole cell lysates,
1% NP-40 was added, and the cells were thawed, incubated on
ice for 30 min, and centrifuged for 30 min at 32,500 
 
g
 
. Protein
concentrations were determined by the Bio-Rad Protein Assay
kit (Bio-Rad Laboratories).
 
Western Blots.
 
Equal quantities of total cell extracts, cytosolic
proteins, or residual proteins were separated on 7.5% SDS-PAGE
gels, transferred to polyvinylidene difluoride membranes, immu-
nostained by standard methods, and detected on x-ray films by
enzyme-coupled chemiluminescence (New England Nuclear Life
Science Products). The results of Western blots were quantified
densitometrically by PhosphorImager
 
®
 
 (Molecular Dynamics).
 
Activation by UVB.
 
COS cells transfected with the pCMV-
Raf-FLAG vector, donated by Dr. R. Davis (University of Mas-
sachusetts, Worcester, MA), were grown in serum-free DME
without phenol red for 2 d. Cells treated with retinoids and/or
oxygen scavengers as specified in the experiments were irradiated
with UVB at 400 
 
m
 
w/cm
 
2
 
. Cultures were incubated at 37
 
8
 
C for
the indicated time periods and harvested (see below).
 
Enzyme Assays.
 
Endogenous cRaf/mitogen-activated pro-
 
tein kinase (MAPK) activity was detected by Western blot with
the phospho-ERK–specific antibody kit as described by the man-
ufacturer (New England Biolabs, Inc.). To ensure equal loading
of cRaf, the transfer membrane was cut in two, and the segment
containing proteins 
 
.
 
65 kD was immunostained for cRaf protein
and the segment 
 
,
 
65 kD was stained for phospho-ERK. The lat-
ter was then stripped and reprobed with antibody specific for
nonphosphorylated ERK. Films were scanned in the Phosphor-
Imager
 
®
 
, and the results of MAPK activity were corrected for the
amounts of ERK protein present in each sample.
 
PKC Kinase Assay.
 
Detergent lysates of 3T3 cells depleted of
retinol, and repleted for 12 h with 2 
 
m
 
M retinol as described
above and activated by H
 
2
 
O
 
2
 
 without blocking with staurospo-
rine, were immunoprecipitated with PKC
 
a
 
 antibody (Signal
Transduction Laboratories). Kinase activity was determined in
the washed immunoprecipitates with H1 histone as substrate, as
described by Konishi et al. (16).
 
Raf Immunoprecipitation/Kinase Assay.
 
COS-7 cells were trans-
fected by the calcium phosphate method in 60-mm dishes.
Cells were lysed using 100 
 
m
 
l lysis buffer: 50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 2mM EDTA, 1mM EGTA, 1% Triton X-100,
25 
 
m
 
g/ml each leupeptin and aprotinin, 1 mM PMSF, 1 mM
Na
 
3
 
VO
 
4
 
, 30 mM NaF, and 30 mM 
 
b
 
-glycerophosphate. The
lysates were precleared with 30 
 
m
 
l of a 50:50 protein G–aga-
rose slurry, and the Flag-Raf protein was precipitated using 30 
 
m
 
l
of anti-Flag M2 affinity gel (Sigma-Aldrich). The immunoprecip-
itates were washed four times with lysis buffer containing 0.5 M
NaCl, and twice with kinase buffer (35 mM Tris-HCl, pH 7.5,
10 mM MgCl
 
2
 
, 0.5 mM EGTA, and 1 mM Na
 
3
 
VO
 
4
 
. The kinase
reaction was performed in 20 
 
m
 
l kinase buffer using 200 ng of ki-
nase-disabled His-MEK(K97M) (provided by Dr. Kolesnick, Me-
morial Sloan-Kettering Cancer Center, New York, NY) as sub-
strate, 60 
 
m
 
M ATP, and 10 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP (6,000 Ci/mmol).
The reaction was carried out for 20 min at 30
 
8
 
C, and terminated
by the addition of 10 
 
m
 
l 5
 
3
 
 Laemmli buffer.
 
Results
 
The human cRaf-1 fragments spanning amino acids
4–256, or 136–195, comprising the 50–amino acid ZiF do-
main (18) HNFARKTFLKLAFCDICQKFLLNGFRC-
QTCGYKFHEHCSTKVPTMC, corresponding to the
consensus sequence HX
 
12
 
CX
 
2
 
CX
 
n
 
CX
 
2
 
CX
 
4
 
HX
 
2
 
CX
 
7
 
C (H 
 
5
 
histidine, C 
 
5 
 
cysteine, X 
 
5 
 
any amino acid [including
a natural trp residue at position 187]), were fused to the Gst
gene and expressed in 
 
E
 
.
 
 coli
 
. Expressed proteins, referred
to below as Gst-Raf ZiF, were purified by affinity chroma-
tography to 
 
.
 
90% purity and tested for the ability to bind
retinol. Studies of the interaction of retinol with proteins
is often confounded by the hydrophobic nature of this
ligand, which renders standard binding assays unsuitable for
quantitative measurements. In contrast, fluorescence-based
methodologies allow monitoring of the binding of retinol
in protein binding sites without the need for physical sepa-
ration of bound and free species. Thus, four fluorescence-
based methods were used to investigate the characteristics
of the interactions of retinol with the ZiF domains of cRaf
and PKC: quenching of intrinsic protein (trp) fluorescence;
resonance energy transfer of intrinsic protein fluorescence
(FRET); enhancement of retinol fluorescence; and expres-
sion of vibronic fine structure. 
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Quenching of the Intrinsic Fluorescence of the Protein upon
Ligand Binding.
 
Because the absorption spectrum of ret-
inol significantly overlaps with the emission spectrum of
tryptophan and tyrosine residues, binding of retinol is often
accompanied by quenching of the intrinsic protein fluores-
cence (26). The data in Fig. 1 show that binding of a stoi-
chiometric amount of retinol to the ZiF domain of cRaf
indeed resulted in a decrease of the protein fluorescence,
and this was accompanied by FRET as evidenced by a
small, but distinctive, retinol fluorescence with the charac-
teristic emission maximum at 466 nm. To determine the
binding affinity, retinol was added in increments, and the
protein fluorescence emission was measured after each ad-
dition. Plotting the fluorescence intensity versus retinol
concentration yielded, after correction for inner filtering,
clear evidence for saturable binding with a calculated affin-
ity of 22 
 
6 
 
3.5 nM (Fig. 2). Titrations of retinol were also
evaluated by FRET (Fig. 3). Using Gst-Raf Zif
 
136–195
 
, pro-
tein-saturable binding was observed and an affinity constant
of 25.8 nM was computed. A truncated protein, Gst-Raf
Zif
 
136–186
 
, which lacked the trp residue at position 187 cru-
cial for protein fluorescence, did not elicit a FRET signal,
although by fluorescence enhancement (see below) this
protein bound retinol with similar affinity.
The binding of retinoid was dependent on the confor-
mation of the protein, as shown for Gst-Raf Zif
 
4–256, since
denaturation by guanidine hydrochloride abolished binding
(14HRR and retinol behaved similarly). Renaturation of
the protein restored saturable binding (Fig. 4).
cRaf is not unique in its ability to bind retinol, as a simi-
lar result was obtained with Gst fusion proteins comprising
the first ZiF domain, C1A, of PKCa, or the C1B ZiF do-
mains of PKCd, or both human and mouse KSR, but not
that of human Vav (data not shown). With the Drosophila
and yeast PKC C1A ZiF Gst fusion proteins, both quench-
ing and FRET were pronounced, especially when retinol
was added in threefold molar excess (data not shown). Ti-
trations of retinol yielded saturable binding at nanomolar
Figure 1. Quenching of protein fluorescence and resonance energy
transfer. Fluorescence emission spectra of 250-nM solution of Gst fusion
protein comprising amino acids 136–195 of human cRaf-1, excited at
280 nm in the presence (solid line) or absence (dashed line) of 250 nM
all-trans retinol (Rol) and spectrum of retinol in buffer (dotted line). A
fluorescence peak at 466 nm, although small, indicated energy transfer
(inset). The naturally occurring trp residue at position 187 may not be
optimally placed for efficient energy transfer.
Figure 2. Determination of binding constant by fluorescence quench
method. The 500-nM solution of Gst-Raf ZiF136–195 fusion protein in
PBS was titrated with all-trans retinol added in 25-nM increments (e).
Fluorescence intensity values (excitation at 280 nm; emission at 330 nm)
corrected for inner filtering were plotted versus retinol concentration. Af-
finity constants were computed according to Norris et al. (reference 25).
Shown are the vehicle control (h), a titration of retinol in tryptophana-
mide solution (d), and Gst protein (n).
Figure 3. Determination of binding constant by fluorescence resonance
energy transfer. All-trans retinol was added in 25-nM increments to a
500-nM solution of the Gst fusion protein comprising the cRaf fragment
136–195, containing a natural trp residue at position 187 (open squares),
or to a truncated fragment 136–186 (crossed squares).The protein was ex-
cited at 280 nm, and the emission of retinol monitored at l max466 nm.
The binding constant of the former protein was calculated according to
Norris et al. (reference 25), whereas the latter did not elicit FRET.839 Hoyos et al.
affinity with stoichiometry consistent with a single binding
site. The affinity constants based on a minimum of four in-
dependent titrations are summarized in Table I.
Not All ZiF Domains Bind Retinol. By the criterium of
fluorescence quenching, the C1B domains of human
PKCa, Drosophila and yeast PKC, and the Vav ZiF do-
main, as mentioned, do not bind retinol with appreciable
affinity, indicating specificity on the part of the protein. To
further test for binding specificity, several unrelated signal
transduction proteins were investigated, including ras,
Hsp90, 14-3-3, immunophilin p50, and the pleckstrin ho-
mology domain of PKCm (27), all expressed as Gst fusion
proteins, as well as Gst protein itself. None of these showed
quenching of the protein emission spectrum, suggesting,
but not proving, that retinol does not interact with these
proteins (Fig. 2, and data not shown).
Fluorescence Enhancement Assays. Binding to the Raf
ZiF fusion proteins was confirmed independently by en-
hancement of the retinol fluorescence emission spectrum
excited at lmax 325 nm. Increased quantum yield results
from movement of the ligand, retinol, from polar solvent
to nonpolar environment of the binding pocket. This is
shown qualitatively for PKCa C1A and PKCd C1B (Fig.
5), as well as quantitatively for Gst-Raf ZiF136–195 and the
trp-minus Raf ZiF136–186 fragment (Fig. 6). Using titrations
of retinol, binding was found to be saturable. The calcu-
lated binding constant was comparable to that obtained
from protein quenching experiments. Fluorescence en-
hancement measurements were extended to the mamma-
lian, Drosophila, and yeast PKC ZiF domains, yielding very
similar results to the results of quench assays (see Table I).
Vibronic Fine Structure. Ligation of retinol by proteins
has been shown to impose a planar conformation on the
ligand, resulting in a red shift in the retinol fluorescence ex-
citation spectrum and expression of vibronic fine structure.
It is known, for example, that the completely enclosed, bar-
rel-shaped binding pocket of cellular retinol binding pro-
tein induces a profound red shift and vibronic fine structure
(28; Fig. 7). Binding of retinol to Saccharomyces cerevisiae
PKC1 or the PKCd C1B ZiF (Fig. 7 A) as well as the
mammalian ZiFs, PKCa C1A and cRaf, and the Drosophila
PKC C1A ZiF (data not shown) produced distinct red shift
and partial fine structure although the magnitude of the ef-
fect was smaller than the one observed with the cellular ret-
inol binding protein (CRBP)–retinol complex. The distinct
Figure 4. Dependence of retinoid binding on protein conformation.
The 1-mM solution of Gst-Raf4–256 was titrated with 14HRR and fluo-
rescence quenching was monitored (excitation at 280 nm; emission at 330
nm). The native protein (j) showed saturable binding, whereas binding
was lost after denaturation with guanidine hydrochloride (d). Binding
was restored after renaturation (h).
Table I. Binding Constants of Raf and PKC Cys Domain
for Retinol
ZiF domain Amino acids Binding constant
nM 6 SE
Human cRaf-1 C1 4–271 21.3 6 3.0
Human cRaf-1 C1 136–195 22.0 6 3.5
Human PKCa C1A 37–87 20.7 6 4
Human PKCa C1B w100–151 .500
Human PKCd C1A 159–209 95.2 6 1.3
Human PKCd C1B 231–280 67.3 6 1.3
Human PKCm C1A 34–290 18.1 6 8
Human PKCm C1B w263–328 17.3 6 4
Human PKCz C1 123–182 34.1 6 6.7
Drosophila PKC C1A 42–102 18.5 6 3.7
Drosophila PKC C1B 107–161w .500
S. cerevisiae PKC C1A w415–461 17.9 6 5.1
S. cerevisiae PKC C1B 476–531 .500
Human Vav C1 464–518w .500
Summary of binding constants. Recombinant Gst fusion proteins
encompassing the indicated ZiF domains of cRaf and various PKC
isoforms were obtained at .90% purity. Where no endogenous one
existed, a trp residue (w) was engineered at the position indicated.
Binding constants and SE covering at least four independent
measurements were calculated from fluorescence quench curves of
tryptophan emission as shown in Fig. 2. Values obtained by fluorescence
enhancement were in close agreement with values obtained by the trp
quench method.
Figure 5. Enhancement of
fluorescence emission of bound
retinol. The fluorescence emis-
sion spectrum (excitation at 325
nm) of a 250-nM all-trans retinol
solution is shown in PBS (dashed
line), and in stoichiometric mix-
tures with Gst PKCa C1A (solid
line) or Gst PKCd C1B fusion
proteins (broken line).840 Zinc Finger Domains Bind Retinoids
shoulders in the excitation spectrum elicited by bound ret-
inol occurred at 348 and 365 nm (Fig. 7 A, arrows) and
hence coincided with the reported peaks of retinol–CRBP
as well as the naturally planar retinoid, 14HRR. Mixing
retinol with the fusion proteins comprising the Drosophila
C1B or PKCa C1B ZiF domain did not result in enhanced
fluorescence emission of retinol, red shift, or vibronic fine
structure (data not shown), confirming binding selectivity
on the part of different ZiF domains. As will be reported
elsewhere in detail HRR, retinoic acid, and AR also bound
cRaf-1 ZiF fusion protein with similar affinity as retinol.
Binding of retinol to full length cRaf and to the ZiF do-
main, expressed as Flag-tagged proteins in COS cells, was
evaluated in vivo by use of 3H-labeled retinol. Fig. 7 B
demonstrates that immunoprecipitates of transfected COS
cells bound retinol. Binding was specific, as free cold retinol
was able to displace radioactive retinol in a dose-dependent
manner.
Retinol as Cofactor in the Alternate Redox Pathway of Activa-
tion. Having established that retinol binds the regulatory
domain of cRaf-1, it was of interest to inquire into the un-
derlying purpose. An exhaustive search of activation of any
kinase cascade by retinol alone was unfruitful. Similarly,
despite our earlier definition of retinol as growth factor (4)
and the demonstration that retinol cooperates with platelet-
derived growth factor (29), attempts to modulate the acti-
vation of the Raf/MAPK pathway by receptor-mediated
stimulation in a variety of cells by retinol, or its active me-
tabolites, 14HRR and AR, produced inconclusive results.
The failure of AR to show any effect in signaling on its
own was intriguing, since AR has been shown to diminish
the survival of a variety of cells types (7), to cause depoly-
merization of actin filaments in fibroblasts (30), and even to
lead to activation of programmed cell death by a mecha-
nism involving conventional kinases (10). Because retinoids
did not appear to intersect with conventional phosphoryla-
tion signal cascades, attention was focused on the alternate
redox activation pathway that recently has been shown to
control both PKC and cRaf/MAPK (15, 16, 31). Both
have been shown to become catalytically active under oxi-
dizing conditions.
To test whether retinol could influence the redox activa-
tion of cRaf, Jurkat cells grown under retinol-free condi-
tions were replenished with different concentrations of ret-
inol, activated by peroxide 15 min later, and analyzed for
endogenous MAPK activity using phospho-ERK measure-
ments on Western blots (32). A distinct dose-dependent
enhancement of MAPK activation by retinol was evident
(Fig. 8 A). To determine dose responses of peroxide on
cRaf, 3T3 fibroblasts were first depleted of endogenous re-
Figure 6. Determination of binding constants by fluorescence en-
hancement. The Gst-Raf136–195 (h) and Gst-Raf136–186 (d) fusion protein
solutions (250 nM) was titrated with all trans-retinol added in 25-nM in-
crements. Retinol was excited at 325 nm and the fluorescence intensity
was monitored at 466 nm. Binding constants were computed according
to Norris et al. (reference 25).
Figure 7. Red shift and vibronic fine
structure of bound retinol. (A) Retinol was
ligated to equimolar solutions of ZiF do-
mains of human PKCd C1B (solid line), S.
cerevisiae (Sc.) PKC1 C1A (broken line), or
CRBP (dashed line), or dissolved in Tris
buffer (dotted line). In the fluorescence ex-
citation spectra shown, monitored at the
retinol lmax 466 nm, the red shift is pro-
nounced and vibronic fine structure
developed partially as three distinct shoul-
ders at wavelengths 330, 348, and 365 nm
(arrows) after ligation to the human or yeast
PKC ZiF domain. Vibronic fine structure is
maximal in the retinol–CRBP complex
(reference 28). (B) Retinol binds to cRaf in
vivo. COS cells expressing Flag-tagged
cRaf (n 5 4) or cRaf ZiF fragment (n 5 2)
were loaded with the indicated concentra-
tions of unlabeled retinol, followed by 3H-
retinol. Values for radioactivity in immuno-
precipitates were corrected for radioactivity
in control immunoprecipitates from non-
transfected cells.841 Hoyos et al.
tinoids by extended culturing (4–5 d) in serum-free me-
dium. One set of cultures was subsequently replenished
with a physiological amount of retinol at 2 mM, added 12 h
before the experiment. Because PKC binds retinol, is acti-
vated by H2O2, and can activate the downstream cRaf ki-
nase, this pathway was blocked by brief culture with stau-
rosporine. Different doses of H2O2 were added, and the
cells were harvested, lysed, and analyzed by Western blot
(Fig. 8 B), with subsequent quantitation by densitometry
(Fig. 8 C). In the representative experiment shown in Fig.
8 B as well as four others, ERK1 and 2 phosphorylation
was significantly higher in retinol-containing compared
with retinol-free cultures over the entire dose range (P ,
0.002). The shift in the H2O2 dose–response indicated that
retinol increased the sensitivity to redox activation. Activa-
tion by 5% FBS showed no differences between retinol-
sufficient and retinol-deficient cultures. To test whether
the kinetics of activation were changed by retinol, three
sets of cultures were compared with each other: 3T3 cells
grown continuously in 2 mM retinol (Fig. 9 A, top), 3T3
cells depleted of retinol then reconstituted with retinol 12 h
before the experiment, and retinol-deficient 3T3 cells. The
results of activation by 300 mM H2O2 (Fig. 9 A) and their
quantitation by imaging of phosphorylated p42, corrected
for the amount of nonphosphorylated p42 detected on the
same membrane, are shown in Fig. 9 B. Measurements of
phosphorylated p44 yielded similar results (data not
shown). These data indicate that MAPK activities peaked
around the same time (10–15 min), but were two- to
threefold higher in retinol-repleted cultures compared with
retinol-deficient ones.
As PKCa bound retinol with an affinity comparable to
that of cRaf and is known to undergo activation by the re-
dox pathway (15, 16, 33), it was of interest whether retinol
acted as a costimulator in this circumstance as well. 3T3
cells were rendered retinol deficient and subsequently re-
Figure 8. Retinol enhances the oxidative activation of cRaf/MAPK.
(A) Jurkat cells grown in serum-free medium were activated for 10 min
with 100 mM H2O2 in the presence of different concentrations of retinol.
3T3 fibroblasts were starved of retinol for 4 d, and part of the cultures was
reconstituted with 2 mM retinol overnight. Cells were then blocked with
25 nM staurosporine and activated for 15 min with H2O2. (B) Western
blot showing phosphorylation of endogenous ERK1 and 2 in retinol-
starved and retinol-reconstituted cultures. (C) Quantitation of the
amounts of phosphorylated ERK2 of 3T3 fibroblasts treated as in A.
Shown are the averages of four replicate retinol-sufficient cultures
(hatched bars) or retinol-deficient cultures (gray bars) for each H2O2 con-
centration, corrected for amounts of total ERK proteins.
Figure 9. Kinetics of oxidative activation of endogenous cRaf/MAPK.
(A) Western blot showing activation by 100 mM H2O2 of endogenous
ERK1 and 2 in 3T3 fibroblast cultures, passaged continuously in retinol
(Rol)-sufficient medium (top), or starved for 4 d then reconstituted with
retinol (middle), or kept in retinol-deficient medium without reconstitu-
tion (bottom). (B) Quantitation by imaging of the amounts of ERK2
phosphorylation corrected for amounts of nonphosphorylated ERK2.842 Zinc Finger Domains Bind Retinoids
constituted with 2 mM retinol as described above. Cells
were activated for 10 min with different doses of H2O2,
and cytoplasmic extracts were assayed for PKC kinase ac-
tivity by standard immunoprecipitation/kinase assay (16).
The results of Fig. 10 show a marked increase in PKC ac-
tivity when retinol was present compared with its absence.
Retinol caused no intrinsic PKC activation on its own.
The pooled imaging data from 6 independent experiments
yielded a 20-fold increase of PKCa kinase activity at maxi-
mum stimulation (200 mM H2O2) over unstimulated cells
in the presence of retinol, compared with a 7-fold increase
in the absence of retinol, for an overall 3-fold retinol en-
hancement effect (P , 0.001). The optimum dose, deter-
mined at 1 mM (data not shown), was similar to that show-
ing enhancement of the MAPK pathway. Activation of
PKC by 150 nM phorbol ester was not significantly en-
hanced by retinol.
To address the question whether endogenous ROS was
augmented by retinol, COS cells transfected with Flag-
tagged cRaf were irradiated with UVB, known to generate
intracellular singlet oxygen and other ROS (34–37). Test-
ing kinase activity in immunoprecipitated Flag-Raf re-
vealed a modest activation in the absence of retinol and a
substantial (2.2 6 0.4–fold; P , 0.003) augmentation when
cells were replenished with 2 mM retinol (see Fig. 11 A,
representing one of three experiments). Addition of oxy-
gen scavengers, sodium azide (100 mM) and N-acetylcys-
teine (1 mM) abolished the Raf activation. By contrast, ad-
dition of deuterated water known to stabilize singlet
oxygen (37) produced distinct, though moderate, enhance-
ment of Raf activity (Fig. 11 B).
Discussion
The significance of our findings is threefold: first, the
unprecedented binding of vitamin A to the cysteine-rich
region of the regulatory domains of serine/threonine ki-
nases; second, the demonstrated prooxidant effect of ret-
inol; third, the strong correlation between presence of ret-
inol, its binding to PKC and Raf, and the enhancement of
redox activation of catalytic capacity. On that score, the
ZiF domain of serine/threonine kinases qualifies as recep-
tor of retinoids. Our discovery is apt to broaden the field of
retinol physiology, which up to now has been dominated
by retinoic acid as transactivator of nuclear receptors (8, 9).
The newly discovered cytoplasmic retinoid receptors, i.e.,
the ZiF domains of serine/threonine kinases, are ubiqui-
tously expressed and moreover conserved in evolution
from yeast to humans. That the capacity to metabolize ret-
inol to 14HRR and DHR is equally shared by all mamma-
lian and invertebrate cell lines tested (our unpublished re-
sults) implies coevolution of this receptor–ligand system
over millions of years. If so, the binding of retinoids to the
Zif domain must serve a basic function.
Using Gst fusion proteins containing the ZiF domains of
cRaf and four mammalian, one insect, and one yeast PKC
(38) isoforms, binding at an affinity in the range of tens of
nanomoles was established by four fluorimetric assays.
Quenching of the intrinsic protein fluorescence, fluores-
cent resonance energy transfer, enhancement of retinoid
fluorescence, and acquisition of partial fine structure all fur-
nished concordant, and hence conclusive, evidence for
binding (Figs. 1–7). Nonspecific interactions of retinol
with a variety of hydrophobic proteins, some (like 14-3-3
[12], Hsp90, and immunophilins) part of the kinase signal-
ing complexes (11), were not in evidence. Moreover, not
every ZiF domain bound retinol. The C1B domain of
mammalian a isoform, Drosophila and yeast PKC, and the
C1A domain of PKCd bound either with low affinity or
not at all, despite sequence homologies to those that bound
(23), indicating that retinol binding was protein selective.
Moreover, the capacity to bind retinoids was vested in
Figure 10. Retinol as cofactor in the oxidative activation of PKCa.
Normalized results of immunoprecipitation/kinase assays of six indepen-
dent titrations of H2O2 with retinol (Rol)-depleted (white bars) and ret-
inol-reconstituted (black bars) 3T3 fibroblasts. Except for unstimulated
cells, the evaluation by Student’s t test showed significantly higher PKC
kinase activity in retinol-reconstituted cultures for each H2O2 concentra-
tion compared with retinol-deficient cultures (P , 0.001).
Figure 11. (A) Activation of Raf kinase activity by endogenously gen-
erated ROS. Cos-7 cells were activated by UVB in the presence or ab-
sence of retinol (Rol). Raf kinase activity was determined in immuno-
precipitates with anti-Flag antibody. Raf kinase activity was transient,
reaching a maximum at 10 min. (B) Neutralization of ROS by sodium
azide and N-acetylcysteine (L-NAC) resulted in diminished kinase re-
sponse at the 10-min time point, whereas addition of deuterated water
enhanced the kinase response. MEK, MAPK.843 Hoyos et al.
the  tertiary structure, since denaturation of cRaf-1 by
guanidine hydrochloride abolished the binding capacity
and renaturation restored it completely (Fig. 4). As small
lipid-like molecules, retinoids can freely pass through
membranes, have free access to all compartments, and can
rapidly partition to the sites of highest affinity (39), just as
diacylglycerides are presumed to do, unless such sites are
occupied by other ligands. By testing in in vitro assays for
the potential binding interference by known lipid ligands
of cRaf (40, 41) and PKC ZiF domains (17, 18, 42), the ret-
inol binding site was found to be distinct from the binding
sites for acidic lipids (i.e., phosphatidylserine), diacylglyc-
erol, and phorbol ester (our unpublished results). It was
therefore a reasonable assumption that under culture condi-
tions in media containing an excess of retinol (2 mM), all
available sites on PKC and cRaf were occupied by retinol
or the metabolites, 14HRR and DHR, our test cells pro-
ducing no other known retinol metabolites. Attempts to
demonstrate binding of retinol in vivo to cRaf were suc-
cessful although the use of detergents was not permissible
owing to the lipid nature of retinoids. Therefore, only
crude purification of the cRaf complex by immunoprecipi-
tation was achieved, and the exact in vivo binding site in
the complex remained unknown. On the other hand, the
Raf-ZiF fragment bound radioactive retinol in vivo (Fig. 7
B). Displacement of bound by free retinol indicated speci-
ficity.
The function of the class of hydroxylated retinoids in
vivo is best described as survival factor (4, 29). Virtually all
cultured cells tested, whether animal or insect in origin,
have the ability to synthesize 14HRR and DHR (5, 6; our
unpublished results). Many of these are profoundly affected
by vitamin A deprivation, although adaptive mechanisms
must exist whereby cells, and indeed whole animals, can
overcome vitamin A deficiency. The question of how hy-
droxylated retinoids support cell survival is an issue too
complex to address in this report. We have instead focused
on the cRaf and PKCa kinases in order to learn which of
the several known activation pathways may be affected by
bound retinol. Extensive experimentation had convinced
us that retinoids themselves caused neither cytosol-to-
membrane translocation nor catalytic activation of the
cRaf/MAPK complex or the PKCa kinase (Fig. 10). Simi-
larly, the classical receptor-mediated activation pathway of
cRaf/MAPK proved to function largely independently of
retinol. This is shown in the control experiment of Fig. 8,
where stimulation by 5% FBS produced equal MAPK ac-
tivity in retinol-deficient and retinol-sufficient 3T3 cells,
and this result is echoed by the lack of enhancement of
PKC activity stimulated by PMA (Fig. 10).
During the past few years, it has become increasingly
clear that oxidation presents an alternative for activation of
both cRaf and PKC kinases. This “oxidative stress path-
way” has its roots in numerous cell biological observations
that oxidizing agents can cause a broad spectrum of reac-
tions, including lymphocyte proliferation (43) and apopto-
sis. The molecular dissection of this phenomenon has led to
the realization that a variety of well-known transcriptional
regulators, notably nuclear factor kB, AP1, and SP1, and
their upstream signaling cascades respond to oxidative stress
(44–46). PKC in a variety of cells and MAPK in cardiac
myocytes (47) stand out as targets for reactive oxygen.
While oxidative stress has helped to reveal its existence, the
redox pathway may more aptly signify a general regulation
circuit powered by the endogenous redox system of cells
and operative at all times.
PKC has been reported to become readily activated by
H2O2 in vivo, and there is suggestive evidence that oxida-
tive activation can also be accomplished with purified
PKC, although uncontrolled oxidation most often leads to
destruction (15, 33). If the former observation is verified,
the initial chemical reaction is likely to be with the protein
itself. It has also been reported that oxidative activation of
PKC is accompanied by phosphorylation of distinct ty-
rosines in the catalytic domain, implying the recruitment of
an upstream kinase (16). This finding still begs the question
where the initial chemical modification may take place.
Taking into account that the regulatory domains of the
PKC and cRaf kinases contain cysteine-rich domains (41,
48–50), chemically highly susceptible to oxidation, that this
domain contains the retinol binding site, and furthermore
that it is crucial for kinase regulation, the likely target of
oxidation may actually lie in this structure. Although our
cell experiments clearly establish the connection between
retinol, its binding to the ZiF domain, and enzyme activa-
tion by an oxidative step, the chemical proof remains to be
established whether sulfhydryl groups become oxidized. A
precedent for this mechanism, however, has been recently
described for the redox regulation of the bacterial chaper-
one, Hsp33 (20). This enzyme contains a closely related
ZiF structure, which underwent selective oxidation affect-
ing cysteine residues critical for the coordination of zinc.
As this process was reversible by reduction, the authors
suggested that this structure served as a redox switch to turn
on the chaperone under oxidizing conditions and off under
reducing conditions.
How might retinoids come into play? The important
clue is probably the presence of the system of conjugated
double bonds characteristic of all natural retinoids. This
polyene system is responsible for the pro- and antioxidant
properties of the molecule. In other words, the electron
transfer capacity of retinoids is rooted in the p electrons of
the polyene system. In nature, this unique capacity is ex-
ploited in photosynthetic systems for straight electron
transfer from carotene to chlorophyll P680, and in vision to
capture the energy of a photon-excited p electron for
isomerization of 11-cis- to trans-retinal (51). It is conceiv-
able that the polyene of retinol interacts with the microen-
vironment of the protein and exerts a catalyst-like effect.
Redox-sensitive structures (foremost cysteines) of the ZiF
domains might be tagged for preferred oxidation. Our cell
biological data that show heightened sensitivity to oxida-
tive kinase activation (Figs. 8–11) are consistent with this
view.
Peroxide is but one pharmacologic agent that induces
oxidative activation of Raf and PKC. Internally generated844 Zinc Finger Domains Bind Retinoids
oxygen radicals had the same consequence, as demonstrated
by UV irradiation. The presence of free radicals, including
singlet oxygen, was required for kinase activation, since
radical scavengers inhibited kinase activation, whereas deu-
terated water, a known stabilizer of singlet oxygen (37), en-
hanced kinase activation (Fig. 11). Whether by pharmaco-
logic means or by endogenously created oxidizing conditions,
the presence of retinol consistently enhanced the kinase ac-
tivity, implying that retinol functioned as a cofactor in the
redox activation pathway. As PKC and Raf are receptors of
retinoids and are independently activated by a redox step,
chances are that the retinol influence on the protein is a di-
rect one.
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